{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-019301","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2022-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.058992+00:00","generated_at":"2026-06-24T15:05:28.698376+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Processa shareholders approve 3M share increase to Omnibus Incentive Plan; director Islam retires","bullets":["Shareholders approved amendment to 2019 Omnibus Incentive Plan, raising share authorization from 3M to 6M shares.","Dr. Khalid Islam retired from the Board effective as of the July 11, 2022 Annual Meeting.","All five director nominees were elected; say-on-pay and auditor ratification passed.","BD & Company, Inc. ratified as independent auditor for 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-019301","json":"https://secwatch.observer/filing/0001493152-22-019301.json","markdown":"https://secwatch.observer/filing/0001493152-22-019301.md","text":"https://secwatch.observer/filing/0001493152-22-019301.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315222019301/0001493152-22-019301-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315222019301/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T15:05:28.698376+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"68400bc717","claim":"Khalid Islam retired as member of the Board of Directors at Processa Pharmaceuticals, Inc..","evidence_excerpt":"Dr. Khalid Islam, who served as a member of the Board of Directors of the Company (the “Board”) since November 2020, retired from the Board Company effective as of the Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533743/000149315222019301/0001493152-22-019301-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}